| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Endocrinology and Diabetes, Department of Medicine (T.A., S.Ku., M.O., S.Ka.) and Division of RI Laboratory, Biomedical Research Center (T.A., H.Ii.), Saitama Medical University, Saitama 350-0495, Japan; Department of Metabolism/Diabetes and Clinical Nutrition (E.K., M.U.), Nagasaki University Hospital of Medicine and Dentistry, Nagasaki 852-8501 Japan; Department of Endocrinology, Diabetes and Metabolism (H.Ik., Y.Kaw.), Kinki University School of Medicine, Osaka 589-8511, Japan; Third Department of Internal Medicine (T.K., S.T.), Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan; Department of Internal Medicine (T.M.), Saitama Social Insurance Hospital, Saitama 330-0074, Japan; Department of Endocrinology and Metabolism (K.N.), Toranomon Hospital, Tokyo 160-8582, Japan; and Department of Internal Medicine (A.S., Y.Kan.), Keio University School of Medicine, Tokyo 160-8582, Japan
Address all correspondence and requests for reprints to: Takuya Awata, Division of Endocrinology and Diabetes, Department of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan. E-mail: awata{at}saitama-med.ac.jp.
| Abstract |
|---|
|
|
|---|
Objective: A multicenter collaboration study was conducted to clarify the role of the IDDM2 region in Japan.
Subjects and Methods: In total, 661 patients with type 1 diabetes and 706 control subjects were enrolled. The INS variable number of tandem repeat (VNTR) class I/class III status was estimated by genotyping the 23 HphI single nucleotide polymorphism. From surrounding polymorphisms across the insulin gene, we also inferred haplotypes bearing INS VNTR lineages.
Results: The frequency of the class I allele was 99.3% in patients and 96.7% in controls (P < 105), and the class I/III or III/III genotype was found in 1.4% of patients and in 6.4% of controls [odds ratio (OR) 0.20, P < 105]. The class I subdivision revealed IC to increase significantly in patients with type 1 diabetes (P = 0.002), whereas ID did not; the distribution of IC and ID was significantly different between patients and controls (P = 0.014).
Conclusion: The present study certainly shows that the IDDM2 region is also a susceptibility locus in the Japanese population. Furthermore, it was revealed that IC may be more susceptible to type 1 diabetes than ID, which could be evidence that the INS VNTR itself confers susceptibility to type 1 diabetes.
| Introduction |
|---|
|
|
|---|
Therefore, in Asians, clarifying the role of the IDDM2 region in the susceptibility to type 1 diabetes is considered to be an essential issue. However, the association between the INS VNTR and type 1 diabetes in Asians has been still uncertain (2, 13, 14, 15), largely because of the predominance of class I over class III alleles and the small sample size of the previous studies. To overcome this, a multicenter collaboration study in Japan, subsequent to the previous studies (16, 17), was thus conducted to analyze the IDDM2 locus. Furthermore, the heterogeneity of class I or class III alleles and the surrounding polymorphisms, which so far have been scarcely analyzed in Asians, were also determined.
| Subjects and Methods |
|---|
|
|
|---|
A total of 1367 Japanese subjects, including 661 patients with type 1 diabetes and 706 control subjects were studied. An ethics committee from each institute approved the study, and informed consent was obtained from all subjects. The patients with type 1 diabetes consisted of 363 females and 298 males with a mean (±SD) age-at-onset of 29.1 (±17.1) yr. Control subjects consisted of 408 females and 298 males with mean (±SD) age of 36.6 (±13.4) yr. The diagnosis of type 1 diabetes was made by diabetologists according to the criteria of the National Diabetes Data Group (18).
23HphI single nucleotide polymorphism (SNP) and surrounding polymorphisms
More than 50 SNPs were identified in a 7.8-kb region flanking the insulin gene (19). Among them, we identified the 23HphI SNP and nine common SNPs within the 4.1-kb region in which type 1 susceptibility was mapped (20), and a 5-bp insertion/deletion polymorphism at +2336. The 23HphI SNP was typed by PCR-restriction fragment length polymorphism using primers as described previously (21). The SNPs at positions 2733, 2221, +805, +862, +1127, +1140, +1355, +1404, and +1428 were determined by direct sequencing of PCR products, and the insertion/deletion polymorphism at +2336 was determined by PCR and 4% agarose gel electrophoresis. Frequencies of INS haplotypes of each group were inferred using the SNPAlyze V5.1 software (Dynacom, Yokohama, Japan), which applies expectation-maximization (EM) algorithm (22) for haplotype inference.
INS VNTR polymorphism
We determined the exact length of class I alleles in part of the subjects (109 patients and 86 control subjects), and then we checked its correlation with the present subdivision (IC and ID) as defined by haplotype analysis. The exact class I allele lengths were determined by fluorescence-labeled PCR using primers 5FP1 (labeled with 6-carboxyfluorescein) and 5FP2 (23), and capillary electrophoresis. Genomic DNA was subjected to PCR amplification (4 min at 94 C, 1 cycle; 1 min at 94 C, then 10 min at 68 C, 18 cycles; 1 min at 94 C, then 10 min + 15 sec increments per cycle at 68 C, 12 cycles; 10 min at 72 C) using Tbr EXT DNA polymerase (Finzymes Oy, Espoo, Finland). A mixture of PCR products and an internal size standard (GeneScan 1000) were run on ABI PRISM genetic analyzer and size analysis was determined with the GeneScan software (Applied Biosystems Japan Ltd., Tokyo, Japan).
Statistics
The differences in genotype and allele frequencies were assessed by either Fishers exact test or
2 test. The OR and its 95% confidence interval (95% CI) were calculated using Woolfs method. The differences in frequencies of each haplotype were assessed by permutation tests (24) using the SNPAlyze V5.1 software (Dynacom, Chiba, Japan). Continuous clinical data were compared using unpaired Students t test, and the categorical clinical data were compared using Fishers exact test. Statistical significance was defined as P < 0.05.
| Results |
|---|
|
|
|---|
First, we determined the frequencies of INS VNTR class I/class III genotypes and alleles. We found the complete linkage disequilibrium between 23HphI SNP and INS VNTR genotypes in 138 Japanese subjects, whose INS VNTR genotype status was previously determined by Southern blot analysis (13). Furthermore, Stead et al. provided data on their home page (http://www.le.ac.uk/ge/ajj/insulin) showing the linkage disequilibrium between INS VNTR and the 23HphI SNP to be complete in 59 Japanese subjects. Based on the very tight linkage disequilibrium between INS VNTR class I/class III alleles and the 23HphI A/T alleles, respectively, in the Japanese population, we estimated the INS VNTR genotype status by the 23HphI SNP genotype. As shown in Table 1
, the frequency of the INS VNTR class I allele was 99.3% in the patients and 96.7% in the controls (P < 105), and the class I/III or III/III genotype was found in 1.4% of the patients and in 6.4% of the controls (OR 0.20, P < 105).
|
We next estimated haplotype frequencies for the SNPs flanking the INS VNTR and the insertion/deletion polymorphism at +2336. Table 2
shows the estimated INS haplotype frequencies by EM algorithm from the polymorphism data. Stead et al. (19) reported inferred haplotypes in non-Africans, including 59 Japanese subjects (http://www.le.ac.uk/ge/ajj/insulin/haplotypes.html). Following the report, the inferred haplotypes in the present study were named according to bearing INS VNTR lineage. In the present study, we observed an unusual haplotype, which was deduced from a patient with type 1 diabetes, in which only the +2336 variation is different from the IIIAa haplotype; thus that was named IIIAa' (Table 2
). The frequencies of the other inferred haplotypes were all very rare (<107) in each group, and were not shown in Table 2
. Permutation tests were used to assess the statistical significance of the haplotype frequency differences (24).
|
2 = 6.0, P = 0.014), and between young-onset patients and controls (
2 = 14.4, P = 0.0001). As for the class III subdivision, the class IIIA (IIIAa, IIIAa', or IIIAb) was predominant over class IIIB in the controls, and only IIIAa and IIIAb haplotypes significantly decreased in the patients in comparison to the controls, although the difference in the class III subset distribution failed to reach statistical significance (
2 = 3.9, P = 0.144). INS genotypes with class I subdivision
Diplotypes of each individual were assigned using maximum-likelihood estimation by EM algorithm, and were named as genotypes of bearing INS VNTR lineages. Table 3
shows the frequencies of the INS genotypes with the class I subdivision. Among the class I/I subjects, only the IC/IC genotype was significantly increased in the patients (OR 1.38). In young-onset patients, the frequencies of the IC/IC and IC/ID genotypes significantly increased, whereas the ID/ID genotype was significantly decreased in type 1 diabetes compared with control subjects. According to the findings of a contingency table analysis, global distribution of the class I/I genotypes with the subdivision was significantly different between young-onset patients and controls (
2 = 16.0, P = 0.0003), although that was not significant between whole patients and controls (
2 = 5.6, P = 0.060).
|
Previously, INS VNTR class I alleles in the Japanese population were subdivided into 1S (2538 repeats), 1M (3941 repeats), and 1L (4244 repeats) based on the repeat number (15). According to the web site by Stead et al. (http://www.le.ac.uk/ge/ajj/insulin), it appears that IC corresponds to 1S and ID to 1M or 1L. Therefore, regarding the genotype, IC/IC, IC/ID, ID/ID, IC/III, and ID/III correspond to 1S/1S; 1S/1M or 1S/1L; 1M/1M, 1M/1L, or 1L/1L; 1S/III; and 1M/III or 1L/III, respectively. In the present study, among 195 Japanese subjects (109 patients and 86 controls; 187 class I/I and eight class I/III), 185 genotypes (94.9%) follow this correspondence.
Clinical characteristics of patients and INS genotypes
Sex, mode of onset (acute, fulminant, or slow), glutamic acid decarboxylase antibody positivity, IA-2 antibody positivity, and coexistence of autoimmune thyroid disease, defined as Graves disease, Hashimotos thyroiditis, or positivity for antibodies against thyroid peroxidase and/or thyroglobulin, were similar among the INS VNTR genotype groups (IC/IC, IC/ID, ID/ID, or I/III) and they were not significantly different (data not shown). However, the age at onset was significantly older in ID/ID patients than both IC/IC and IC/ID (P = 0.028 and 0.0034, respectively).
| Discussion |
|---|
|
|
|---|
We further assessed the heterogeneity of class I and class III alleles in relation to disease susceptibility. Nevertheless, because of the limited number of class III alleles in the present study, it was difficult to assess the heterogeneity in class III-associated protection. We observed that the protection of the class IIIA (particularly IIIAa) was stronger than that of class IIIB in terms of the significance level (Table 2
), although the difference in the class III subset distribution was not significant. Therefore, in line with the recent report on Caucasians (25), we could not confirm that the class IIIB-bearing haplotype, previously called very protective haplotype, was more protective than the class IIIA-bearing haplotype, called protective haplotype (26). However, further accumulation of subjects with sufficient number of class III alleles is necessary to clarify the heterogeneity in class III-associated protection in the Japanese population.
Regarding the class I subdivision, we found some evidence that the IC haplotype is more susceptible to type 1 diabetes than the ID (Tables 2
and 3
). Because these IC and ID haplotypes are identical at the 4.1-kb IDDM2-encoded susceptibility region (20, 27) except for the VNTR, the variability of the class I alleles (http://www.le.ac.uk/ge/ajj/insulin/classI.html) may thus modulate the susceptibility to type 1 diabetes. In a previous study in the Japanese population (15), class I alleles were divided into 1S (2538 repeats), 1M (3941 repeats), and 1L (4244 repeats), and the 1S allele and the 1S/1S genotype were found to be both significantly increased in 152 patients, in comparison to the 167 control subjects. Because a close correlation was observed between IC and 1S, and between ID and 1M or 1L, the present collaboration study principally confirms the findings of the previous study (15); note that only 86 control subjects (no patients) from the previous study were included in the present study, and the significant differences between IC and ID remained after removing the overlapping 86 control subjects (data not shown).
Heterogeneity in class I-associated susceptibility to type 1 diabetes has also been analyzed in Caucasians. Bennett et al. (26, 28) reported that the most common 814 allele (42 repeats, ID) was not significantly transmitted from class I/III heterozygous fathers. Similarly, analyzing a subset of the same families, Stead et al. (29) found that the ID alleles, which include the 814 allele, showed a protective effect when transmitted from ID/III heterozygous fathers. However, the anomalous behavior of a specific size of class I allele was not confirmed by McGinnis and Spielman (30). Recently, Barratt et al. (25) reported that, with a large sample, they failed to replicate any inhomogeneity in susceptibility to type 1 diabetes within class I or class III allele groups (25), which definitely ruled out any difference between IC and ID. In the present study, in contrast, we provide evidence, albeit weak, for a difference of susceptibility to type 1 diabetes between IC and ID in the Japanese population. A lower impact of HLA class II (DRB1, DQB1)-associated susceptibility to type 1 diabetes in the Japanese population (31, 32) may have facilitated the evaluation of non-HLA, minor susceptibility genes to type 1 diabetes. However, the case-control studies used in this study tend to involve population stratification. Family-based studies and further transracial studies, including Asian and African populations, are necessary to replicate our findings and help elucidate the role of VNTR variability in disease susceptibility.
In the present study, the age at onset was found to be significantly older in ID/ID patients than both IC/IC and IC/ID, and consequently, the association of the class I subdivision with type 1 diabetes was more evident in the young-onset patients as shown in Tables 2
and 3
, which may indicate that INS VNTR could affect the disease progression, or alternatively, adult-onset type 1 diabetes may be etiologically more heterogeneous in terms of autoimmunity to insulin. However, age-dependent influences of INS VNTR, which appear to be unclear in previous studies, need to be proven in independent studies.
In conclusion, the present study strongly shows the IDDM2 region to also be a susceptibility locus in the Japanese population, thus suggesting that insulin is an important autoantigen across different ethnic groups. Furthermore, the subdivision of class I alleles revealed that IC may be more susceptible to type 1 diabetes than ID in the Japanese population, which could be evidence that the INS VNTR itself confers susceptibility to type 1 diabetes, although further confirmation studies are necessary.
| Acknowledgments |
|---|
| Footnotes |
|---|
First Published Online March 6, 2007
1 Members of the Japanese Study Group on Type 1 Diabetes Genetics are: Takuya Awata, Hiroshi Ikegami, Eiji Kawasaki, Tetsuro Kobayashi, Taro Maruyama, Koji Nakanishi, Akira Shimada, and Kazuma Takahashi. ![]()
Abbreviations: CI, Confidence interval; EM, expectation-maximization; OR, odds ratio; SNP, single nucleotide polymorphism; VNTR, variable number of tandem repeats.
Received October 13, 2006.
Accepted February 22, 2007.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Awata, E. Kawasaki, S. Tanaka, H. Ikegami, T. Maruyama, A. Shimada, K. Nakanishi, T. Kobayashi, H. Iizuka, M. Uga, et al. Association of Type 1 Diabetes with Two Loci on 12q13 and 16p13 and the Influence Coexisting Thyroid Autoimmunity in Japanese J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 231 - 235. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |